Targeting Tumor and Nerve Communication Opens New Horizons for Neuromodulatory Cancer Delivery
Researchers propose shifting cancer therapeutics toward neuromodulatory delivery platforms that selectively disrupt communication networks between malignant cells and peripheral nerves.
